Verbatim response from Perplexity
Probably not as your best option. Compounded GLP-1s can be a fallback when you cannot access an FDA-approved medication, but the FDA says they are not approved, are not reviewed for safety, effectiveness, or quality, and should generally be used only when an FDA-approved drug cannot meet the patient’s medical need.[2][5] The American Diabetes Association also recommends against non-FDA-approved compounded GLP-1s because of concerns about content, safety, quality, and effectiveness.[11]
What this means in practice:
- If your insurance denied Wegovy, the first move is usually to appeal the denial and ask your clinician to document medical necessity, prior weight-loss attempts, and any qualifying obesity-related conditions.[5][12]
- You should also ask about other FDA-approved options that your plan may cover better, such as Zepbound, Saxenda, or diabetes-indicated GLP-1s if you have type 2 diabetes.[1][11]
- If you and your clinician decide to use a compounded product, the safest approach is a state-licensed U.S. pharmacy with clear verification of ingredients and dosing; the FDA warns that dosing errors and other adverse events have occurred with unapproved GLP-1 products.[2][10][12]
When compounded GLP-1s may make sense:
- You cannot access an FDA-approved GLP-1 because of shortage or a documented medical need that approved products cannot meet.[2][11]
- You are uninsured or underinsured and have no realistic access to brand-name therapy; compounded products can be cheaper, though still often costly out of pocket.[8][14]
Important cautions:
- Some compounded products include extra ingredients like vitamin B12 that have no proven weight-loss benefit.[1]
- The FDA has noted that compounding of semaglutide and tirzepatide has been constrained as shortages resolved, so availability and legality can change.[1][8]
- Quality can vary by pharmacy, and compounded GLP-1s are not generic Wegovy.[5][9]
If you want, I can help you compare the most practical next steps after a Wegovy denial: appeal strategy, alternative brand-name options, and how to vet a compounding pharmacy.